—
C+
C+ The full Closelooknet — membership. Open the C+ overview

Maravai Lifesciences Holdings Inc (MRVI) — chart, structure and Closelooknet read

Pick a ticker to load its detail page.

Signals for this name

Every Closelooknet reading that exists for MRVI, from the same nightly bakes the boards use. Research diary readings, not advice.

Weather around the name 3 macro readings: Money Temperature, Factor regime, Sovereign pressure

The weather around this name

Macro readings that apply by membership — the regime, the factor tape, the sector cell, the funding backdrop.

  • Money Temperature Composite 61/100 · S&P 500 fund at 75, bullish alignedEight instruments scored on position, momentum, volume, volatility and fragility — the regime every name trades inside. Temperature lab → 2026-10-06
  • Factor regime Momentum leading — risk appetite buildingMomentum against low volatility (SPMO / SPLV): above its 50-day trend, 98th percentile of the window, +5.7% over 20 sessions. Factor regime → 2026-10-06
  • Sovereign pressure Index 0.74 · up 0.17 over 21 sessionsG7 long-end yields, 10s30s and the slope — the funding weather for every balance sheet on this site. Sovereign pressure → 2026-10-06
How it trades on rate days beta 1.74 to TLT · on the worst bond days it fell more than the market

How it trades on rate days

How MRVI has moved when long-dated Treasury yields rise — measured against TLT, the 20+ year Treasury fund.

  • Beta to long bonds, 1 year 1.74 — moves strongly with bonds for every 1% move in TLT (20+ year Treasuries), Maravai Lifesciences Holdings Inc moved 1.74% on average · correlation 0.24 · higher than 98% of US names
  • Beta, last 3 months 2.90 more rate-sensitive lately than over the year
  • On the 10 worst bond days −2.13% on average against −0.74% for the S&P 500 the 10 sessions of the past year in which TLT fell most, i.e. long yields rose most
  • Latest of those days +3.80% TLT −1.29% that day 2026-09-24

Daily total returns from the adjusted price series; a TLT down day is a day long yields rose. Beta = the average move of the name for a 1% move in TLT. Past sensitivity, not a forecast. An investment diary, not a recommendation.

Who it is priced against Biotechnology · United States · 8 names with week and year-to-date

Peer group

Biotechnology · United States

This name carries no Closelooknet score, so its cohort ranks on trend state — distance to the 50- and 200-day averages — never on a score it does not have.

Compared against MRVI on the nightly bakes; the Peers tab ranks the cohort on the Closelooknet scores where it exists.

Company snapshot — Maravai Lifesciences Holdings Inc

MRVI in five paragraphs: what it makes and sells, where it sits in the Closelooknet stack, who it is priced against, why we track it, what we watch. Research diary, not advice.

What it does
Maravai LifeSciences supplies materials that let drugmakers develop new therapies, vaccines, cell and gene treatments, and diagnostics, through two segments, TriLink and Cygnus. TriLink manufactures nucleic acids, messenger RNA, oligonucleotides and CleanCap capping chemistry used in gene therapy and vaccine production. Cygnus makes analytical kits that detect impurities during biologic manufacturing. Its customers are biopharmaceutical companies, academic research institutions and diagnostics firms, and it is headquartered in San Diego.
Where it sits in the stack
Maravai has no seat in Rubin or Halo, our AI build-out indices; it sits instead in the life-sciences tools sleeve of our wider universe, supplying reagents and nucleic-acid building blocks used in biologic and gene-therapy manufacturing rather than any layer of the compute stack.
Who it is priced against
The diary's peer group carries no listed comparators for this name; a well-known public name working in similar nucleic-acid and bioprocess reagent supply is Thermo Fisher Scientific.
Why Closelooknet tracks it
It carries no Closelooknet score and holds no seat in Rubin or Halo; its only recorded index membership is the Russell 1000, and the diary has not quoted or scored it so far.
What the diary watches
The diary watches whether demand from vaccine and gene-therapy developers for nucleic-acid and CleanCap-based building blocks recovers, since that demand feeds the TriLink segment directly.

Maravai Lifesciences Holdings Inc (MRVI) trades on US exchanges.

Written from the company’s public profile and Closelooknet’s own readings, 2026-09-17. Descriptive, refreshed with the registry; corrections welcome via the imprint. closelook.net is an investment research diary — market structure, index membership and scores are our own readings, not investment advice. Related: index compare · sector dispersion · scanner.

The Street on this name 1 analyst action on the wire · latest: initiation by Cowen & Co., 2026-10-05

The Street on this name

Analyst actions and the latest print for MRVI from the Closelooknet wires — third-party opinions on the record, not our readings.

  • Initiation Cowen & Co. — at Buy Initiated to Buy 2026-10-05

1 action on the analyst wire since 2026-08-13: 1 initiation. Analyst wire → · Earnings wire →

FAQ · from the current data · as of 2026-10-07

Quick answers

What is Maravai Lifesciences Holdings Inc (MRVI)?

Maravai Lifesciences Holdings Inc trades as MRVI on the US exchange (United States) in the Closelooknet research universe, as of the registry build of 2026-10-07.

Is MRVI in a Closelooknet index?

Not currently — Maravai Lifesciences Holdings Inc is tracked in the Closelooknet research universe but is not a constituent of a Closelooknet functional index as of 2026-10-07.

Where does MRVI trade against its moving averages?

Uptrend stack intact: Trades +10.1% vs the 50-day and +60.4% vs the 200-day average, 16.7% below the 52-week high and +208.4% off the 52-week low. Computed from daily closes. As of 2026-10-06 — a technical state from the nightly Closelooknet bake, not advice. The Technical tab carries the full row.

How does Maravai Lifesciences Holdings Inc compare with its peers?

Against its peer group (Biotechnology · United States), Maravai Lifesciences Holdings Inc (MRVI) sits 16.7% below its 52-week high, 10.1% above its 50-day average; Ginkgo Bioworks Holdings (DNA) is 31.9% below, Moderna Inc (MRNA) is 11.7% below, Exelixis Inc (EXEL) is 4.6% below. Put any of them next to MRVI in the chart grid (2×1 or 2×2) and the page lays the companies side by side: performance, trend, valuation, margins and our money-flow reading.

How does Maravai Lifesciences Holdings Inc trade when bond yields rise?

Over the past year Maravai Lifesciences Holdings Inc had a beta of 1.74 to TLT, the long-dated Treasury fund — it moves strongly with bonds, higher than 98% of US names. On the 10 sessions in which long bonds fell most it moved −2.13% on average, against −0.74% for the S&P 500. The "How it trades on rate days" block on this page carries the lines.

What does Maravai Lifesciences Holdings Inc do?

Maravai LifeSciences supplies materials that let drugmakers develop new therapies, vaccines, cell and gene treatments, and diagnostics, through two segments, TriLink and Cygnus. TriLink manufactures nucleic acids, messenger RNA, oligonucleotides and CleanCap capping chemistry used in gene therapy and vaccine production. Cygnus makes analytical kits that detect impurities during biologic manufacturing. The diary's peer group carries no listed comparators for this name; a well-known public name working in similar nucleic-acid and bioprocess reagent supply is Thermo Fisher Scientific.

Where does Maravai Lifesciences Holdings Inc sit in the AI build-out?

Maravai has no seat in Rubin or Halo, our AI build-out indices; it sits instead in the life-sciences tools sleeve of our wider universe, supplying reagents and nucleic-acid building blocks used in biologic and gene-therapy manufacturing rather than any layer of the compute stack. It carries no Closelooknet score and holds no seat in Rubin or Halo; its only recorded index membership is the Russell 1000, and the diary has not quoted or scored it so far.

What has Wall Street done on Maravai Lifesciences Holdings Inc recently?

The most recent analyst action on Maravai Lifesciences Holdings Inc on the Closelooknet wire is a initiation by Cowen & Co. on 2026-10-05 (at Buy). 1 action on the analyst wire since 2026-08-13: 1 initiation. Analyst actions are third-party opinions recorded by the wire, not Closelooknet readings. The “The Street on this name” block on this page lists the moves; the full feeds are the analyst wire and the earnings wire.

What does this page show?

A live price chart with SMA overlays and drawing tools for MRVI, performance metrics, index-membership context and the Closelooknet structure read — an investment research diary view, not investment advice.

Related in the Closelooknet universe

then Biotechnology. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.